| abstract |
The present invention discloses a novel use of a mixture of triterpenoids for the treatment of multiple sclerosis (MS). The triterpene mixture system of Ganoderma acid A (ganoderic acid A, GAA) , Ganoderma acid B (ganoderic acid B, GAB) , Ganoderma acid C (ganoderic acid C, GAC) , Ganoderma acid C 5 (ganoderic acid C 5, GAC 5), Ganoderma acid C 6 (ganoderic acid C 6, GAC 6), Ganoderma acid D (ganoderic acid D, GAD) , Ganoderma acid E (ganoderic acid E, GAE) , Ganoderma acid G (ganoderic acid G, GAG) , And consisting of ganoderenic acid D. The triterpene mixture can be administered to an individual suffering from multiple sclerosis (MS) at a dose of about 1 to 10 mg/kg to alleviate or alleviate the symptoms associated with multiple sclerosis. |